Clinical Trial Detail

NCT ID NCT03578432
Title Everolimus in Restoring Salivary Gland Function in Participants With Locally Advanced Head and Neck Cancer Treated With Radiation Therapy
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors University of Arizona
Indications

head and neck cancer

Therapies

Everolimus

Age Groups:

No variant requirements are available.